{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:26:17Z","timestamp":1789748777171,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T00:00:00Z","timestamp":1431129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T00:00:00Z","timestamp":1431129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Prevalence estimates of ankylosing spondylitis vary considerably, and there are few nationwide estimates. The present study aimed to describe the national prevalence of clinically diagnosed ankylosing spondylitis in Sweden, stratified according to age, sex, geographical, and socio-economic factors, and according to subgroups with ankylosing spondylitis-related clinical manifestations and pharmacological treatment.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>All individuals diagnosed with ankylosing spondylitis according to the World Health Organization International Classification of Disease codes, between 1967 and 2009, were identified from the National Patient Register. Data regarding disease manifestations, patient demographics, level of education, pharmacological treatment, and geographical region were retrieved from the National Patient Register and other national registers.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>A total of 11,030 cases with an ankylosing spondylitis diagnosis (alive, living in Sweden, and 16 to 64 years old in December 2009) were identified in the National Patient Register, giving a point prevalence of 0.18% in 2009. The prevalence was higher in northern Sweden, and lower in those with a higher level of education. Men had a higher prevalence of ankylosing spondylitis (0.23% versus 0.14%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), a higher frequency of anterior uveitis (25.5% versus 20.0%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and were more likely to receive tumor necrosis factor inhibitors than women (15.6% versus 11.8% in 2009, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Women were more likely than men to have peripheral arthritis (21.7% versus 15.3%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), psoriasis (8.0% versus 6.9%, <jats:italic>P<\/jats:italic>\u2009=\u20090.03), and treatment with oral corticosteroids (14.0% versus 10.4% in 2009, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>This nationwide, register-based study demonstrated a prevalence of clinically diagnosed ankylosing spondylitis of 0.18%. It revealed phenotypical and treatment differences between the sexes, as well as geographical and socio-economic differences in disease prevalence.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13075-015-0627-0","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T09:35:54Z","timestamp":1431077754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study"],"prefix":"10.1186","volume":"17","author":[{"given":"Sofia","family":"Exarchou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas K","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Forsblad-d\u2019Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Neovius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Turesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Erik","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart TH","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,9]]},"reference":[{"key":"627_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00002281-200007000-00002","volume":"12","author":"E Feldtkeller","year":"2000","unstructured":"Feldtkeller E, Bruckel J, Khan MA. Scientific contributions of ankylosing spondylitis patient advocacy groups. Curr Opin Rheumatol. 2000;12:239\u201347.","journal-title":"Curr Opin Rheumatol"},{"key":"627_CR2","first-page":"516","volume":"32","author":"H Dagfinrud","year":"2005","unstructured":"Dagfinrud H, Kjeken I, Mowinckel P, Hagen KB, Kvien TK. Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions. J Rheumatol. 2005;32:516\u201323.","journal-title":"J Rheumatol"},{"key":"627_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/rheumatology\/ker169","volume":"51","author":"LE Kristensen","year":"2012","unstructured":"Kristensen LE, Petersson IF, Geborek P, Joud A, Saxne T, Jacobsson LT, et al. Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study. Rheumatology (Oxford). 2012;51:243\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"627_CR4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1136\/ard.2011.151027","volume":"70","author":"J Braun","year":"2011","unstructured":"Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, et al. 2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70:896\u2013904.","journal-title":"Ann Rheum Dis"},{"key":"627_CR5","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1136\/ard.2004.029207","volume":"64","author":"A Saraux","year":"2005","unstructured":"Saraux A, Guillemin F, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E, et al. Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis. 2005;64:1431\u20135.","journal-title":"Ann Rheum Dis"},{"key":"627_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2474-11-98","volume":"11","author":"I Anagnostopoulos","year":"2010","unstructured":"Anagnostopoulos I, Zinzaras E, Alexiou I, Papathanasiou AA, Davas E, Koutroumpas A, et al. The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord. 2010;11:98.","journal-title":"BMC Musculoskelet Disord"},{"key":"627_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10067-005-1106-9","volume":"24","author":"P Trontzas","year":"2005","unstructured":"Trontzas P, Andrianakos A, Miyakis S, Pantelidou K, Vafiadou E, Garantziotou V, et al. Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheumatol. 2005;24:583\u20139.","journal-title":"Clin Rheumatol"},{"key":"627_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/rheumatology\/keh133","volume":"43","author":"Y Alamanos","year":"2004","unstructured":"Alamanos Y, Papadopoulos NG, Voulgari PV, Karakatsanis A, Siozos C, Drosos AA. Epidemiology of ankylosing spondylitis in Northwest Greece, 1983\u20132002. Rheumatology (Oxford). 2004;43:615\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"627_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/03009740600904243","volume":"36","author":"R De Angelis","year":"2007","unstructured":"De Angelis R, Salaffi F, Grassi W. Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study. Scand J Rheumatol. 2007;36:14\u201321.","journal-title":"Scand J Rheumatol"},{"key":"627_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/03009740903544212","volume":"39","author":"P Hanova","year":"2010","unstructured":"Hanova P, Pavelka K, Holcatova I, Pikhart H. Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scand J Rheumatol. 2010;39:310\u20137.","journal-title":"Scand J Rheumatol"},{"key":"627_CR11","first-page":"1591","volume":"19","author":"K Johnsen","year":"1992","unstructured":"Johnsen K, Gran JT, Dale K, Husby G. The prevalence of ankylosing spondylitis among Norwegian Samis (Lapps). J Rheumatol. 1992;19:1591\u20134.","journal-title":"J Rheumatol"},{"key":"627_CR12","first-page":"496","volume":"24","author":"O Kaipiainen-Seppanen","year":"1997","unstructured":"Kaipiainen-Seppanen O, Aho K, Heliovaara M. Incidence and prevalence of ankylosing spondylitis in Finland. J Rheumatol. 1997;24:496\u20139.","journal-title":"J Rheumatol"},{"key":"627_CR13","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/art.21577","volume":"53","author":"G Bakland","year":"2005","unstructured":"Bakland G, Nossent HC, Gran JT. Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis Rheum. 2005;53:850\u20135.","journal-title":"Arthritis Rheum"},{"key":"627_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/ard.44.6.359","volume":"44","author":"JT Gran","year":"1985","unstructured":"Gran JT, Husby G, Hordvik M. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, northern Norway. Ann Rheum Dis. 1985;44:359\u201367.","journal-title":"Ann Rheum Dis"},{"key":"627_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/ard.2010.141598","volume":"70","author":"E Haglund","year":"2011","unstructured":"Haglund E, Bremander AB, Petersson IF, Strombeck B, Bergman S, Jacobsson LT, et al. Prevalence of spondyloarthritis and its subtypes in southern Sweden. Ann Rheum Dis. 2011;70:943\u20138.","journal-title":"Ann Rheum Dis"},{"key":"627_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","volume":"41","author":"J Braun","year":"1998","unstructured":"Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum. 1998;41:58\u201367.","journal-title":"Arthritis Rheum"},{"key":"627_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00296-008-0809-z","volume":"29","author":"YJ Xiang","year":"2009","unstructured":"Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China. Rheumatol Int. 2009;29:481\u201390.","journal-title":"Rheumatol Int"},{"key":"627_CR18","first-page":"554","volume":"28","author":"S Hukuda","year":"2001","unstructured":"Hukuda S, Minami M, Saito T, Mitsui H, Matsui N, Komatsubara Y, et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol. 2001;28:554\u20139.","journal-title":"J Rheumatol"},{"key":"627_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/BF03342637","volume":"15","author":"MA Khan","year":"1996","unstructured":"Khan MA. Epidemiology of HLA-B27 and arthritis. Clin Rheumatol. 1996;15:10\u20132.","journal-title":"Clin Rheumatol"},{"key":"627_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/ard.2010.133371","volume":"70","author":"M Neovius","year":"2011","unstructured":"Neovius M, Simard JF, Askling J. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis. 2011;70:624\u20139.","journal-title":"Ann Rheum Dis"},{"key":"627_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"},{"key":"627_CR22","unstructured":"WHO International Classification of Disease codes. http:\/\/www.who.int\/classifications\/icd\/en\/."},{"key":"627_CR23","unstructured":"Lindstr\u00f6m U, Exarchou S, Sigurdardottir V, Sundstr\u00f6m B, Askling J, Eriksson JK, et al. Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register. Scand J Rheumatol. 2015;23:1-8. [Epub ahead of print]"},{"key":"627_CR24","doi-asserted-by":"crossref","unstructured":"Kristensen LE, Jakobsen AK, Askling J, Nielsson FX, Jacobsson LT. Safety of etoricoxib, celecoxib and non-selective NSAIDs in ankylosing spondylitis and other spondyloarthritis patients: a Swedish national population based cohort study. Arthritis Care Res. 2015. doi: 10.1002\/acr.22555. [Epub ahead of print]","DOI":"10.1002\/acr.22555"},{"key":"627_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/annrheumdis-2012-202634","volume":"73","author":"KP Jordan","year":"2014","unstructured":"Jordan KP, Joud A, Bergknut C, Croft P, Edwards JJ, Peat G, et al. International comparisons of the consultation prevalence of musculoskeletal conditions using population-based healthcare data from England and Sweden. Ann Rheum Dis. 2014;73:212\u20138.","journal-title":"Ann Rheum Dis"},{"key":"627_CR26","unstructured":"The National Board of Health and Welfare. Coding quality in the patient register - Inpatient register 2008. (Socialstyrelsen. Kodningskvalitet i patientregistret \u2013 Slutenv\u00e5rd 2008). 2010. (Article in Swedish) http:\/\/www.socialstyrelsen.se\/publikationer2010\/2010-6-27."},{"key":"627_CR27","unstructured":"The National Board of Health and Welfare. Coding quality in the patient register - A new tool for measuring quality. (Socialstyrelsen. Kodningskvalitet i patientregistret \u2013 Ett nytt verktyg f\u00f6r att m\u00e4ta kvalitet). 2013. (Article in Swedish) http:\/\/www.socialstyrelsen.se\/publikationer2013\/2013-3-10."},{"key":"627_CR28","unstructured":"The Swedish prescribed drug register (L\u00e4kemedelsregistret) (Page in Swedish). http:\/\/www.socialstyrelsen.se\/register\/halsodataregister\/lakemedelsregistret."},{"key":"627_CR29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1136\/ard.2005.045872","volume":"65","author":"J Askling","year":"2006","unstructured":"Askling J, Fored CM, Geborek P, Jacobsson LT, van Vollenhoven R, Feltelius N, et al. Swedish registers to examine drug safety and clinical issues in RA. Ann Rheum Dis. 2006;65:707\u201312.","journal-title":"Ann Rheum Dis"},{"key":"627_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/03009742.2014.927918","volume":"44","author":"H Wadstr\u00f6m","year":"2015","unstructured":"Wadstr\u00f6m H, Eriksson JK, Neovius M, Askling J, ARTIS Study Group. How good is the coverage and how accurate are data in the swedish biologics register? Scand J Rheumatol. 2015;44:22\u20138.","journal-title":"Scand J Rheumatol"},{"key":"627_CR31","unstructured":"Statistics Sweden. http:\/\/www.scb.se\/en_\/."},{"key":"627_CR32","unstructured":"The Swedish cause-of-death register (D\u00f6dsorsaksregistret) (Page in Swedish). http:\/\/www.socialstyrelsen.se\/register\/dodsorsaksregistret."},{"key":"627_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","volume":"24","author":"JF Ludvigsson","year":"2009","unstructured":"Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24:659\u201367.","journal-title":"Eur J Epidemiol"},{"key":"627_CR34","first-page":"S127","volume":"27","author":"J Zochling","year":"2009","unstructured":"Zochling J, Braun J. Mortality in rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 2009;27:S127\u201330.","journal-title":"Clin Exp Rheumatol"},{"key":"627_CR35","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/1471-2474-14-352","volume":"14","author":"S Exarchou","year":"2013","unstructured":"Exarchou S, Redlund-Johnell I, Karlsson M, Mellstrom D, Ohlsson C, Turesson C, et al. The prevalence of moderate to severe radiographic sacroiliitis and the correlation with health status in elderly Swedish men - the MrOS study. BMC Musculoskelet Disord. 2013;14:352.","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0627-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-015-0627-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0627-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0627-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:36:16Z","timestamp":1728923776000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-015-0627-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,9]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["627"],"URL":"https:\/\/doi.org\/10.1186\/s13075-015-0627-0","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,9]]},"assertion":[{"value":"22 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"118"}}